Boltz PBC has announced a collaboration with Takeda to deploy its advanced biomolecular artificial intelligence models and platform across Takeda’s research organisation.

Jazz Pharmaceuticals and AbCellera have entered into a preclinical research collaboration, option and licence agreement to discover and develop next-generation T-cell engaging (TCE) multispecific antibodies for gastrointestinal (GI) cancers and other solid tumours.

Eli Lilly and Company has acquired 4E Therapeutics, an Austin-based neuroscience company focused on developing non-opioid treatments for chronic pain. Financial terms of the transaction were not disclosed.

Johnson & Johnson has announced an investment of more than $1 billion to expand its vision care operations in Jacksonville, Florida, strengthening its manufacturing, packaging and distribution capabilities in the United States.

PharmaEssentia has received approval from Taiwan’s Ministry of Health and Welfare (MOHW) for BESREMi® (ropeginterferon alfa-2b-njft) to treat adult patients with essential thrombocythaemia (ET)

Antengene has received Investigational New Drug (IND) approval from China’s National Medical Products Administration (NMPA) to begin the Phase I ATTRACT study of ATG-201, a CD19

Engitix has entered into a strategic research collaboration and option agreement with GSK to identify and validate novel therapeutic targets aimed at promoting liver fibrosis regression.

Chai Discovery has entered into a licensing agreement with Pfizer to support the use of artificial intelligence in drug discovery and accelerate the development of new medicines.

Alnylam Pharmaceuticals, Inc. and Inceptive Nucleics, Inc. have entered into a strategic collaboration aimed at accelerating the discovery and development of RNA interference (RNAi) therapeutics through the use of artificial intelligence.

First Foundation Labs (1FL), a life sciences artificial intelligence company established by Luma Group, has announced a collaboration with Microsoft to support the development and enterprise deployment of its